Five things worth your attention this Sunday.
1. A weight-loss drug just became medicine
India’s drug regulator approved Novo Nordisk’s semaglutide, sold here as Wegovy, for metabolic fatty liver disease on 17 July (The Hindu BusinessLine). Until this week the molecule had one mainstream Indian use: weight loss. The distinction matters commercially. A weight-loss prescription is discretionary spending that people abandon once the scale moves. A liver-disease prescription comes with a diagnosis, a specialist, and years of managed adherence. Hepatology surveys put fatty liver at close to a third of Indian adults. The constraint is price: GLP-1 therapy still costs more per month than most policies reimburse, and the disease is concentrated well below the income band buying Wegovy today.
2. Netflix stops showing its homework
Netflix beat estimates on 17 July with revenue up about 13%, then lost close to a tenth of its market value in a day (NDTV Profit). The forecast for the coming quarter came in soft, and the company said it will report less viewership data going forward. Price increases and the ad-supported tier did most of the revenue work this quarter, and both are levers you pull once. Neither tells an investor how many people actually watched anything. The ad tier is the part that needs the numbers most, because advertisers price inventory on reach. Cutting disclosure while growth slows is a decision about what the market is allowed to measure.
3. E-commerce gets one lobby desk
IAMAI launched the E-Commerce Council of India on 17 July, pulling marketplaces, brands, logistics firms, payment providers, exporters and MSMEs into a single body for a sector it sizes at $120 billion (The Hindu BusinessLine). Indian digital commerce has spent years arguing with itself in public: marketplaces against sellers, quick commerce against kirana associations, D2C brands against platform fees. Regulators have been reading contradictory submissions from the same industry. The harder part is that member interests genuinely diverge, and consolidating six positions into one usually means the largest members set it.
4. Maharashtra buses cost 13% more
Maharashtra raised state bus fares by more than 13% from 18 July, citing diesel prices, and withdrew the earlier 10% seasonal surcharge on ordinary buses (NDTV Profit). State transport is the cheapest intercity option for households that do not own a vehicle, which is most of the state outside the metros. This lands on daily commuters and small-town traders, not on discretionary travel. It also reads as a marker of how fuel costs are moving through the economy: companies absorbed diesel for two quarters, and public transport has stopped absorbing it. Every rupee added to a commute is a rupee that does not reach a shelf.
5. Textiles booked Rs 14,300 crore
Bharat Tex closed with about $2 billion in buyer enquiries and roughly Rs 14,300 crore in investment commitments across more than 30 MoUs, organisers said on 17 July (The Hindu BusinessLine). Enquiries are not orders and MoUs are not factories. The number worth watching is the investment commitment, because textiles is the rare sector where India’s labour cost advantage still converts directly into capacity. Bangladesh’s disruption and China’s cost inflation have both loosened, and buyers are hunting a third source rather than a replacement. The gap that remains is man-made fibre, where global demand sits and Indian strength does not.
Read today’s full edition, including Apple retaking the top spot from Nvidia: https://theinsightlabs.in/daily/2026-07-19
Hit reply and tell me which one you want taken apart properly.
— Satyam · The Insight Labs